193 related articles for article (PubMed ID: 8750809)
1. Complement anaphylatoxin C3a and C5a formation in premature children with respiratory distress.
Enskog A; Bengtsson A; Bengtson JP; Heideman M; Andreasson S; Larsson L
Eur J Pediatr; 1996 Jan; 155(1):41-5. PubMed ID: 8750809
[TBL] [Abstract][Full Text] [Related]
2. Anaphylatoxins in preterm and term labor.
Soto E; Romero R; Richani K; Espinoza J; Nien JK; Chaiworapongsa T; Santolaya-Forgas J; Edwin SS; Mazor M
J Perinat Med; 2005; 33(4):306-13. PubMed ID: 16207115
[TBL] [Abstract][Full Text] [Related]
3. Perioperative effect of methylprednisolone given during lung surgery on plasma concentrations of C3a and C5a.
Mikawa K; Ikegaki J; Maekawa N; Hoshina H; Tanaka O; Goto R; Obara H; Kusunoki M
Scand J Thorac Cardiovasc Surg; 1990; 24(3):229-33. PubMed ID: 2293363
[TBL] [Abstract][Full Text] [Related]
4. In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells.
Shivshankar P; Li YD; Mueller-Ortiz SL; Wetsel RA
FASEB J; 2020 Jun; 34(6):7540-7560. PubMed ID: 32301538
[TBL] [Abstract][Full Text] [Related]
5. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.
Haeger M; Bengtson A; Karlsson K; Heideman M
Obstet Gynecol; 1989 Apr; 73(4):551-6. PubMed ID: 2784554
[TBL] [Abstract][Full Text] [Related]
6. Complement anaphylatoxins C3a and C5a: Emerging roles in cancer progression and treatment.
Ajona D; Ortiz-Espinosa S; Pio R
Semin Cell Dev Biol; 2019 Jan; 85():153-163. PubMed ID: 29155219
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary injury induced by C3a and C5a anaphylatoxins.
Stimler NP; Hugli TE; Bloor CM
Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
[TBL] [Abstract][Full Text] [Related]
8. Complement factors C3a and C5a mimick a proinflammatory microenvironment and increase HBV IGRA sensitivity.
Bröker K; Terzenbach R; Bentzien F; Lüth S; Dammermann W
J Transl Med; 2019 Jan; 17(1):6. PubMed ID: 30602374
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
[TBL] [Abstract][Full Text] [Related]
10. C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a.
Chen NJ; Mirtsos C; Suh D; Lu YC; Lin WJ; McKerlie C; Lee T; Baribault H; Tian H; Yeh WC
Nature; 2007 Mar; 446(7132):203-7. PubMed ID: 17322907
[TBL] [Abstract][Full Text] [Related]
11. Alterations in systemic complement component 3a and 5a levels in patients with cerebral arteriovenous malformations.
Haque R; Hwang BY; Appelboom G; Piazza MA; Guo K; Connolly ES
J Clin Neurosci; 2011 Sep; 18(9):1235-9. PubMed ID: 21742500
[TBL] [Abstract][Full Text] [Related]
12. Anaphylatoxins in fresh-frozen plasma.
Sonntag J; Stiller B; Walka MM; Maier RF
Transfusion; 1997 Aug; 37(8):798-803. PubMed ID: 9280323
[TBL] [Abstract][Full Text] [Related]
13. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells.
Monsinjon T; Gasque P; Chan P; Ischenko A; Brady JJ; Fontaine MC
FASEB J; 2003 Jun; 17(9):1003-14. PubMed ID: 12773483
[TBL] [Abstract][Full Text] [Related]
14. Early plasma complement C3a levels correlate with functional outcome after aneurysmal subarachnoid hemorrhage.
Mack WJ; Ducruet AF; Hickman ZL; Garrett MC; Albert EJ; Kellner CP; Mocco J; Connolly ES
Neurosurgery; 2007 Aug; 61(2):255-60; discussion 260-1. PubMed ID: 17762737
[TBL] [Abstract][Full Text] [Related]
15. The role of the complement anaphylatoxins in the recruitment of eosinophils.
DiScipio RG; Schraufstatter IU
Int Immunopharmacol; 2007 Dec; 7(14):1909-23. PubMed ID: 18039528
[TBL] [Abstract][Full Text] [Related]
16. Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
Marceau F; Hugli TE
J Pharmacol Exp Ther; 1984 Sep; 230(3):749-54. PubMed ID: 6332191
[TBL] [Abstract][Full Text] [Related]
17. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells.
el-Lati SG; Dahinden CA; Church MK
J Invest Dermatol; 1994 May; 102(5):803-6. PubMed ID: 7513741
[TBL] [Abstract][Full Text] [Related]
18. Lower circulating levels of complement split proteins C3a and C4a in maternal plasma of women with gestational diabetes mellitus.
Lappas M
Diabet Med; 2011 Aug; 28(8):906-11. PubMed ID: 21615487
[TBL] [Abstract][Full Text] [Related]
19. Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality.
Hamed ME; Naeem A; Alkadi H; Alamri AA; AlYami AS; AlJuryyan A; Alturaiki W; Enani M; Al-Shouli ST; Assiri AM; Alosaimi B
J Clin Immunol; 2021 Oct; 41(7):1607-1620. PubMed ID: 34232441
[TBL] [Abstract][Full Text] [Related]
20. Time-course analysis of C3a and C5a quantifies the coupling between the upper and terminal Complement pathways in vitro.
Morad HO; Belete SC; Read T; Shaw AM
J Immunol Methods; 2015 Dec; 427():13-8. PubMed ID: 26391915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
